Schedule 13G ownership disclosure
CYCLACEL PHARMACEUTICALS INC
Security class unavailable · CUSIP: 23254L603
Event date: 2022-08-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 648,752
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001943462-22-000001
- Form type
- SC 13G
- Filer
- Bio Green Med Solution, Inc.
- CIK
- CIK 1130166
- Filed
- Aug 22, 2022
- Reporting period
- Aug 11, 2022
- Description
- Schedule 13G beneficial ownership